We hypothesized that estradiol levels are higher in prepubertal girls than in prepubertal boys and that this greater secretion of estradiol might drive the more rapid epiphyseal development and earlier puberty in girls. Since previous estradiol assays have lacked adequate sensitivity to test the hypothesis of higher estradiol levels in girls, we developed a new ultrasensitive assay to measure estrogen levels. The assay uses a strain of Saccharomyces cerevisiae genetically engineered for extreme sensitivity to estrogen. Yeast were transformed with plasmids encoding the human estrogen receptor and an estrogen-responsive promoter fused to the structural gene for f-galactosidase. Ether extracts of 0.8 ml of serum were incubated with yeast for 8 h and the 38-galactosidase response was used to determine estrogen bioactivity relative to estradiol standards prepared in charcoalstripped plasma. The assay was highly specific for estradiol with < 3 % cross-reactivity with estrone, estriol, or estradiol metabolites. The detection limit was < 0.02 pg/ml estradiol equivalents (100-fold lower than existing assays). Using this assay, we measured estrogen levels in 23 prepubertal boys (9.4±2.0 yr) and 21 prepubertal girls (7.7+1.9 [SD] yr). The estrogen level in girls, 0.6+0.6 pg/ml estradiol equivalents, was significantly greater than the level in boys, 0.08+0.2 pg/ml estradiol equivalents (P < 0.05). We conclude that the ultrasensitive recombinant cell bioassay for estrogen is approximately 100-fold more sensitive than previous estradiol assays, that estrogen levels are much lower prepubertally, in both sexes, than reported previously, and that prepubertal girls have 8-fold higher estrogen levels than prepubertal boys. (J. Clin. Invest. 1994Invest. . 94:2475Invest. -2480
precedes thelarche, suggesting that skeletal growth can be driven by still lower levels of estradiol (2) . Androgens are unlikely to be the cause of this growth spurt, since the onset of the growth spurt in boys is much later than in girls, despite their having equal or higher levels of androgen. Consistent with this view, the infusion of estradiol at the dose of 4 ,ug/d causes a tripling of ulnar growth rate in boys (3) . The plasma estradiol level corresponding to this dose is -4 pg/ml based on extrapolation from the levels at higher dose infusions. Additionally, ethinyl estradiol doses as low as 25-100 ng/kg per day cause increased growth velocity in girls with Turner syndrome (4) (5) (6) .
We hypothesized that circulating levels of estradiol in girls are higher than in boys and that this estradiol drives skeletal growth and maturation. This hypothesis would explain the observation that skeletal maturation proceeds more rapidly in prepubertal girls than boys (7) . Furthermore, children with luteinizing hormone-releasing hormone-independent precocious puberty, who initially have high sex steroid levels but low gonadotropin levels, have an earlier pubertal rise in gonadotropin levels than normal children (8) . By analogy, the hypothesis of higher prepubertal estradiol levels in girls might also explain the observation of an earlier onset of puberty in girls than in boys (2) .
The possibility of higher estradiol levels in girls than in boys has not been resolved previously because of the lack of sensitivity of available assays for estradiol. Previous reports of estradiol levels in prepubertal children include the observation by Forest et al. (9) and others ( 10-12) of a neonatal surge of estradiol and descriptions by others of estradiol levels in older prepubertal children that were -8 pg/ml and were similar in both boys and girls (13) (14) (15) (16) . These levels were so close to the detection limit of the assay that they were of questionable reliability ( 13) . Thus, to test the hypothesis of greater secretion of estradiol in prepubertal girls than in prepubertal boys, we developed a new ultrasensitive recombinant cell bioassay (RCBA)1 to measure extremely low levels of estrogen. We used this assay to measure estrogen levels in 44 normal prepubertal girls and boys.
Methods
Plasmids. The plasmid, YEPKB1, contains the CUPI metallothionein promoter fused to the human estrogen receptor cDNA. The reporter plasmid, YRPE2, contains two copies of the frog vitellogenin estrogen response element (ERE) upstream of the yeast iso-l-cytochrome c promoter fused to the structural gene for /-galactosidase. The Saccharo-1. Abbreviations used in this paper: CV, variation; DES, diethylstilbestrol; ERE, estrogen response element; ONPG, ortho-nitrophenolgalactopyranoside; RCBA, recombinant cell bioassay. myces cerevisiae strain BJ3505 (MATa, tryplA0l, was transformed with these two plasmids (17) (18) (19) . Transformants were selected by tryptophan or uracil auxotrophy (20, 21) .
Standards. Pooled plasma from adult men plus charcoal (3 g/100 ml)(Norit A; Fisher Scientific Co., Fairlawn, NJ) was stirred for 30 min at room temperature and then overnight at 4°C and then was filtered successively through glass wool and a 0.2-yrm filter (Corning Glassworks, Corning, NY). A known amount of estradiol (Sigma Immunochemicals, St. Louis, MO) was dissolved in ethanol (Midwest Grain Products, Pekin, IL) and diluted serially in ethanol to yield concentrations from 5 x 10-12 to 5 x 10-' M. 0.05 ml of each solution of estradiol was added to 25 ml of charcoal-stripped plasma to obtain a set of estradiol standards with concentrations from 10-13 to 10-7 M.
Each standard pool was divided into aliquots of 1.6 ml and frozen for future use.
Standards were prepared in charcoal-stripped plasma to avoid a negative blank that occurred when ether extracts of plasma were assayed against an estradiol standard curve that had not been exposed to plasma (data not shown).
Blood collection and serum separation. Blood was collected in glass vacutainer tubes that were kept upright at all times to avoid contamination with substances in the rubber stoppers that otherwise cross-reacted in the assay. Blood was spun, and the serum phase was removed and immediately frozen in polypropylene tubes.
Extraction. Ether (0. /3-Galactosidase assay. /3-Galactosidase activity was assayed by a modification of previous methods (22, 23) . After incubation, the yeast culture samples were transferred to conical 0.6-ml RIA tubes (so that a multitip pipetter could be used throughout the remainder of the assay for efficiency and reproducibility) (Sarstedt, Inc., Newton, NC) and centrifuged at 4,000 g for 10 min at 4°C to pellet the cells. The supernatant was removed by suction, and the cells were resuspended in 150 yd of Z buffer (Na2HPO4 7H2O 16 
Results
Standard curve. Known amounts of estradiol were added to charcoal-stripped plasma samples (Fig. 1) . The background activity in the absence of estradiol was very low. The P-galactosidase activity increased 1,000-fold in response to estradiol. The working range of the assay was also at least three orders of magnitude of estradiol concentration.
Sensitivity. The sensitivity of the assay, defined as the estradiol concentration that resulted in /3-galactosidase activity 2 standard deviations above the mean of 10 samples of charcoalstripped plasma, was < 0.02 pg/ml.
Precision. The intraassay variation (CV) was estimated by assaying the same plasma pool eight times in a single assay. At 2 pg/ml estradiol, the intraassay CV was 15%. As one approached the detection limit of 0.02 pg/ml, the CV increased to 50%. The interassay variation was estimated by assaying duplicate samples from a plasma pool on six separate days. At 2 pg/ml estradiol, the interassay CV was 13%. As one approached the detection limit, the interassay CV increased to 60%. The assay was highly specific for estradiol with low crossreactivity for estrone (0.3%), DES (< 3%), estriol (0.03%), estrogen metabolites (< 2%) (Fig. 3) , testosterone, aldosterone, progesterone, and cortisol (< 0.01%, data not shown). The cross-reactivity for commonly used synthetic estrogens was 100% for ethinyl estradiol and 0.4% for mestranol. 17-a estradiol had a cross-reactivity of 9% (data not shown).
Recovery
Patient data. The mean estrogen level in prepubertal boys was 0.08±0.2 pg/ml estradiol equivalents (range < 0.02 to 0.7 pg/ml) (Fig. 4) . The mean estrogen level in prepubertal girls, 0.6±0.6 pg/ml estradiol equivalents (range < 0.02-2.2 pg/ ml), was significantly greater (P < 0.05) (Fig. 4) . Estradiol levels did not correlate significantly with age or body mass index in girls or boys and did not correlate with testicular volume in boys (data not shown).
Discussion
We have developed a new ultrasensitive RCBA to measure estrogen with a sensitivity of < 0.02 pg/ml estradiol equivalents. Most commercially available radioimmunoassays for estradiol report detection limits of 10-20 pg/ml. The best research assays report detection limits of 2-10 pg/ml. Therefore, the sensitivity of this assay is at least 100-fold greater than the best existing research assays. The first estrogen assays were bioassays based upon biological effects such as vaginal comification (25), vaginal mitosis and epithelial thickening (26) , vaginal metabolic activity (27) , and uterine weight (28) (29) (30) . Physico-chemical methods were next used, including colorimetry (31), fluorimetry (31, 32), gas-liquid chromatography, and radioimmunoassay (33) . By the early 1970s, radioimmunoassays for estradiol, estrone, and estrone sulfate had been developed which had sensitivities as low as 5 pg/ml (34) (35) (36) (37) (38) (39) (40) . Antibodies against estradiol were discovered subsequently that permitted sensitivities as low as 2 pg/ml (41, 42) . The ultrasensitive RCBA, by exploiting the potential for signal amplification in a genetically engineered biological system, further increases the sensitivity of estrogen measurement by two orders of magnitude.
There are several possible explanations for the greatly increased sensitivity of this assay compared with radioimmunoassays. First, the human estrogen receptor is probably overexpressed in this system. Therefore, even if the fraction of occupied estrogen receptors is low at the least detectable concentration, the actual concentration of occupied receptors Estrogen Levels in Children may still reach the threshold for biological activity. Second, the frog vitellogenin ERE produces a high-amplitude response to estrogen and the tandem arrangement of two EREs in the reporter plasmid may amplify the effect. Third, the very low background in the absence of estrogen and the 1,000-fold amplification by estrogen also contribute to assay sensitivity.
The assay was unexpectedly specific for estradiol compared with other estrogens such as estrone and estriol. The explanation may lie in part with the ether extraction. There may also be an intrinsically greater activation of the estrogen receptor/ERE complex in this system by estradiol than by the other estrogens. Other theoretical explanations for the specificity for estradiol include greater metabolism of estrone or estriol by the yeast during the 8-h incubation, or a greater adsorption of estrone or estriol by nonreceptor components of the incubation. Regardless of mechanism, however, the practical implication is that estradiol is the principal endogenous compound that reacts in the assay.
We have used this assay to measure estrogen levels in normal prepubertal girls and boys. The mean level in girls was 0.6 pg/ml estradiol equivalents. The mean level in boys was 0.08 pg/ml estradiol equivalents. Previous reports of estradiol levels in prepubertal children include the description by descriptions by others of estradiol levels in older prepubertal children that were -8 pg/ml and were similar in both boys and girls (Fig. 5) (13-16) . However, we conclude that these measurements in older prepubertal children, which were near the detection limit of the radioimmunoassays, primarily reflected assay blank, since the levels in both sexes were at least 10-fold higher than were obtained with the ultrasensitive assay (Fig. 5 ).
There was no correlation between estrogen levels and age, body mass index, or testicular volume in our normal prepubertal subjects. However, more patients, covering a wider range of age and body mass, are needed to define the effect of age and body mass on estrogen level during the prepubertal years.
Our results indicate that prepubertal girls have significantly higher estrogen levels than prepubertal boys. We hypothesize that the higher estradiol levels in prepubertal girls may contribute to their greater rate of skeletal maturation, their earlier pubertal onset, and, ultimately, their earlier cessation of growth, in comparison to boys. Comparison between estrogen levels. Estrogen levels in prepubertal girls and boys by the ultrasensitive RCBA (solid bars) and previously reported estradiol levels by an RIA (hatched bars) (13) . *P < 0.05 compared with the levels measured by the same assay in boys.
The availability of this new ultrasensitive assay makes it possible to address previously unanswerable questions concerning the role of estrogen in normal and pathologic states. Potential physiologic applications include an improved understanding of estrogen secretion during infancy (9-11), childhood ( 12, 13, 37) , and menopause (38) (39) (40) , including the diurnal variation in secretion and the potential cyclicity associated with premenarcheal follicular maturation and atresia (43) . Pathologic applications include the pathophysiology of premature thelarche (44) , the differential diagnosis and monitoring of treatment for precocious puberty (45) , and optimization of treatment for estrogendependent neoplasms such as breast cancer (46) . The assay should also help clarify the role of estrogen in normal male physiology and in feminizing disorders. Much future work will be needed to address these and other areas.
